Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-03-28 @ 1:56 PM
Study NCT ID:
NCT02819804
Status:
TERMINATED
Last Update Posted:
2020-02-11
First Post:
2016-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor:
Northwestern University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-17
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-28
First Submit QC Date:
None
Study First Post Date:
2016-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-21
Results First Submit QC Date:
None
Results First Post Date:
2020-01-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-31
Last Update Post Date:
2020-02-11
Last Update Post Date Type:
ACTUAL